
GLP-1 drug spending surges and rewires diabetes care as session at teh 2026 PBMI Annual National Conference spotlight PBM disruption, AI-driven actionable data, and new state reporting rules.

GLP-1 drug spending surges and rewires diabetes care as session at teh 2026 PBMI Annual National Conference spotlight PBM disruption, AI-driven actionable data, and new state reporting rules.

A number of pharmacy benefit managers are creating programs geared to the healthcare needs of women.

Implementation costs, structural pressures and the labor-intensive nature of healthcare mean that artificial intelligence is unlikely to dramatically lower its costs, at least in the short term.

Philip Mease, M.D., of the Swedish Medical Center, Providence St. Joseph Health in Seattle, and Saakshi Khattri, M.D., of the Icahn School of Medicine at Mount Sinai in New York, discussed the Be Bold trial.

Christine Poh, M.D., of the City of Hope Los Angeles, discusses follicular lymphoma treatment.

In a wide-ranging interview, the CEO of the Association for Community Affiliated Plans (ACAP) discusses Medicaid enrollment, Medicaid work requirements, the ACA marketplace plan, her 25 years at the helm of ACAP and whether she is burnt out.